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ABSTRACT 
 
This paper synthesises the findings of, and distils lessons from a study which has sought to 
illuminate the process of bioscience innovation in three East African countries:  Kenya, Tanzania 
and Uganda.  More specifically, we attempt to trace specific efforts to foster biotechnology 
innovations in those countries and to determine in what ways and to what extent the innovation 
system in place impinges on the final outcome of those innovations. The paper concludes with a 
set of policy recommendations that may enhance bioscience innovations in East Africa. 
 
In all three countries covered by the study, science, technology and innovation are central to 
recent policy discussions and policy development. However, despite these policy objectives, 
current government expenditure on research is relatively low, and still very much dependent on 
external donor funding. Promising steps are made in setting up new institutions and national 
funding mechanisms to encourage research and innovation. 
 
The study underpinning this paper has reviewed the national innovations systems in place in the 
three countries, conducted a survey of research institutions and analysed the trajectories of 
specific biotechnology innovations. These include, in the case of Kenya, biotic and abiotic stress 
tolerant sorghum varieties, and, cassava genetic improvement and clean seed production; in the 
case of Uganda, “epuripur” (sorghum) production and production of clean sweet potato planting 
materials; and, in the case of Tanzania, bioenergy from sisal waste and wastewater treatment 
through constructed wetlands. In terms of progress achieved in the innovation cycle, three of the 
cases (epuripur, bioenergy from sisal waste and constructed wetlands) have been successfully 
transferred from research, through product development to a final biotechnology innovation 
adopted by clients. In the other three cases, while strong advances have been made in 
collaborative research and in product development, the potential innovations are still in the 
testing / pilot phase. All cases point to the crucial role of an individual research scientist acting as 
“product champion”, and close (though informal) linkages between the R&D organizations and 
technology customers. 
 
There is no single, one-fits-all solution to successful technological innovation.  Indeed, there may 
be a number of possible pathways to success.  What is important in current and future bioscience 
programs is to identify demand for a specific technology, and to plot the essential links as early 
as possible in the research, development, dissemination process. The question of demand is 
crucial in making an assessment as to whether a particular innovation may have commercial 
prospects and can therefore be distributed in a market context, through commercial channels,  or 
whether it has no immediate market prospects but, because it is considered important for 
environmental or social reasons (and therefore a “public good” technology) needs to be 
developed and disseminated in a non-market context, through public authorities, community 
groups, farmers’ groups, or NGOs. 
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I. INTRODUCTION 
 
This paper synthesises the findings of a study which has sought to illuminate the process of 
bioscience innovation in three East African countries: Kenya, Tanzania and Uganda. More 
specifically, it has attempted to trace specific efforts to foster biotechnology innovations in those 
countries and to determine in what ways and to what extent the innovation system in place 
impinges on the final outcome of those innovations. 
 
Supported by and focused in part on elements of the BIO-EARN
1
 programme, the study 
reviewed the national innovations systems in place in the three countries, conducted a survey of 
research institutions and analysed the trajectories of specific biotechnology innovations. These 
include, in the case of Kenya, biotic and abiotic stress tolerant sorghum varieties and cassava 
genetic improvement and clean seed production: in the case of Uganda, Epuripur and sweet 
potato vines: and, in the case of Tanzania, bioenergy from sisal waste and constructed wetlands. 
Thus, the case studies relate to both environmental/industrial and agricultural biotechnology 
innovations. 
 
For the purposes of this study, an innovation is conceived as knowledge produced formally 
through research and development and knowledge which may originate from informal and 
indigenous sources, combined to produce value. The value created is realised through the 
introduction of a new product (a good or a service) to the market, the introduction of a new 
process that produces products for the market, or delivers them; the use of new organizational 
structures or business practices; or the development of new markets, or the capturing of a greater 
share of existing markets.   The concept of the innovation system is based on the premise that the 
flow of information, knowledge and technology among people, institutions and enterprises is key 
to the innovative process.   It encompasses the interaction (or links) between the different actors 
who are needed in order to turn an idea or successful research results into a process, product or 
service which has economic value (Brenner, 1997). These interactions are schematically 
presented in Figure 1 below; while specifically focused on agricultural biotechnology 
innovations, this figure applies to other types of bioscience innovations as well. 
 
This chapter attempts to distil overall lessons from the country studies contributed by Kenya, 
Tanzania and Uganda. In Section II the national innovation frameworks are reviewed as they 
relate to policies, institutions and financial and human resources.  In Section III the case studies 
are briefly presented followed by overall findings from these experiences.  Finally, in Section IV, 
conclusions are drawn, recommendations made and implications outlined for future bioscience 
innovation initiatives. 
 
                                                 
1 BIO-EARN: Eastern Africa Regional Programme and Research Network for Biotechnology, Biosafety and Biotechnology 
Policy Development. URL: www.bio-earn.org  
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Figure 1. Biotechnology in a National System of Innovation 
 
 
 
Source: Brenner, C. 1997. Biotechnology Policy for Developing Country Agriculture. Policy Brief No.14. Paris: 
OECD Development Centre.
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II. BIOSCIENCE INNOVATION FRAMEWORKS: POLICIES, INSTITUTIONS, 
RESOURCES 
 
With growing acknowledgment of the strategic importance of science, technology and 
innovation in national economic development and in competitiveness, innovation is currently at 
the forefront of policy preoccupations in all three countries. 
 
Kenya has a National Science and Technology Act (1977) and is in the process to draft a science, 
technology and innovation (STI) policy which proposes, inter alia, the creation of science and 
technology parks.  Reorganisation of the National Council for Science and Technology is also 
planned, as is the creation of two new institutions, a National Science Foundation and a National 
Innovation Agency.   An Innovation Fund, established in 2006, disbursed funding of 450 million 
Kenya shillings (approximately US$ 6.42 million) between 2007 and 2009.   In parallel with the 
proposed institutional changes, indicators to evaluate research funding and national STI 
capacities are also being developed.    
 
Within the broader national STI context, biotechnology has been targeted as a strategic priority.  
The National Biotechnology Development Policy (2006) provides a clear framework and vision 
for biotechnology application in Kenya, while the Biosafety Act of 2009 provides the framework 
for biotechnology regulations. The Act has established a National Biosafety Authority, which is 
now functional. 
 
Tanzania is in the final stages of revising its STI policy, which commits government to promote 
innovations. In addition, a National Biotechnology Policy was passed in May 2009. This policy 
has a vision to develop a viable and competitive biotechnology industry in Tanzania. The 
Ministry of Communication, Science and Technology (MCST) is responsible for matter of 
science and technology, with the Commission of Science and Technology (COSTECH) as one of 
its semi-autonomous agencies. COSTECH is the secretariat of the National Biotechnology 
Advisory Committee (NBAC) which advises the government on matters relating to research and 
the safe application of biotechnology.  Biosafety regulation is coordinated by the National 
Biosafety Committee under the Division of Environment in the Office of the Vice President. 
 
In Uganda, a national S&T policy was first proposed in 1991.  However, it was not until 2008 
that the proposal was submitted and until August 2009 that the national STI policy was finally 
approved.  The National Agricultural Research Policy was adopted in 2005.   As in the other two 
countries, biotechnology has been targeted as a strategic area in Uganda and a National 
Biotechnology and Biosafety Policy was approved by government in April 2008.  It is also 
anticipated that a National Biosafety Bill will be approved in the near future. 
 
The Uganda National Council for Science and Technology (UNCST), a semi-autonomous 
agency under the aegis of the Ministry of Finance, Planning and Economic Development and the 
Parliamentary Committee on Science and Technology (PCS&T), established in 2003 to oversee 
matters of STI in Parliament, are the bodies responsible for STI governance.  
   
Despite recent stated policy objectives, current government expenditure on research is relatively 
low in the three countries. Comparative data on R&D expenditures are scarce, but a number of 
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initiatives are under way to remedy that situation.  For example, the NEPAD African Science 
Technology & Innovation Indicators Initiative (ASTII) initiative is currently under way to 
develop comparative STI indicators for 19 countries, including Kenya, Tanzania and Uganda.  
The ASTII data will be collected and stored by the African Observatory for Science, Technology 
and Innovation, which is being set up in Equatorial Guinea by the African Union.  
 
Compared with levels in industrialised countries, expenditure on R&D is currently low in the 
three countries. For example, between 1995 and 2004, expenditure was as low as <0.1 per cent of 
its gross domestic product (GDP) in Tanzania. Of this, 14 per cent was contributed by 
government, 51 per cent by foreign sources, 31 per cent from income generation and 4 per cent 
by local donors.  Recently the Tanzanian government has announced its intention of increasing 
R&D expenditures to 1 per cent of GDP. 
 
In Uganda, total expenditure on R&D as a percentage of GDP averaged 0.3 per cent between 
2003/04 and 2007/8.  This is low compared with between 0.8 and 1 per cent in South Africa and 
4 per cent in Sweden.  
 
New financing mechanisms for stimulating innovation are, however, emerging.  In Kenya, the 
ministries of Higher Education, Science and Technology (MoHEST) and the Ministry of 
Agriculture (MoA) have both had innovation funds operating since 2007. In Uganda, the 
government’s Millennium Science Initiative (MSI), co-financed by the government and the 
World Bank, is implemented by the UNCST.  By the end of 2008, a total of 27 competitive 
grants had been awarded, the largest being US$0.8 million for a period of three years, and 
US$1.25 million for creating new and/or upgrading undergraduate science and engineering 
degree programmes. 
 
There is limited data available on private sector investment in R&D in the three countries but it 
is generally accepted that it is even less than public sector investment. 
 
Similarly, limited comparative quantitative data is available on both the human and financial 
resources devoted to science in general and biotechnology in particular in the three countries.   
The country studies have, however, contributed valuable data on the scientific capacities of the 
major institutions conducting biotechnology research.  These are presented in the individual 
country study reports. 
 
A large share of funding for biotechnology research is contributed by external sources in all three 
countries.  With respect to the BIO-EARN supported activities which are the subject of this 
study, funding has been provided since 1998 by the Swedish International Development Agency 
(SIDA).  Other bilateral donor organisations contributing to biotechnology research in Kenya, 
Tanzania and Uganda include USAID, DFID (UK), DANIDA and GTZ.   The European Union, 
the World Bank, the Rockefeller Foundation, the Bill & Melinda Gates Foundation and AATF
2
 
are among the growing number of organisations which provide financial contributions.  
ASARECA
3
 is a regional organisations concerned with STI in general and agricultural 
biotechnology in particular.  
                                                 
2
 AATF: African Agricultural Technology Foundation 
3
 ASARECA: Association for Agricultural Research in East and Central Africa 
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III. CASE STUDIES 
 
Two case studies were selected for analysis from each country.  They include: 
 
Case 1.Kenya: biotic and abiotic stress tolerant sorghum varieties 
Case 2.Kenya: cassava genetic improvement and clean seed production 
 
Case 3.Uganda: Epuripur: production of sweet sorghum for brewing industries  
Case 4.Uganda: micropropagation of virus-free sweet potato 
 
Case 5.Tanzania:bioenergy from sisal waste  
Case 6.Tanzania:constructed wetlands for wastewater treatment 
 
The cases thus include not only agricultural biotechnology, but also environmental and industrial 
biotechnology, which was a unique feature of the 10-year BIO-EARN programme.  
 
As the case studies are analysed and presented in detail in individual country studies, this chapter 
focuses on synthesizing overall lessons. 
 
III.a Overall findings from case studies 
 
It is useful to keep in mind that, in four of the six cases, research has been supported under the 
BIO-EARN programme for the past 10 years.   
 
In terms of overall progress and the “distance” achieved in the innovation cycle, three of the 
cases (epuripur, bioenergy from sisal waste and constructed wetlands) have been successfully 
transferred from research, through product development to a final biotechnology innovation.  In 
the other three cases, while advances have been made in collaborative research and in product 
development, the potential innovations have not yet been disseminated. 
 
Case 1:  Biotic and abiotic stress tolerant sorghum varieties 
 
Research efforts to develop biotic and abiotic stress tolerant sorghum varieties have been 
underway since the third phase of the BIO-EARN programme was initiated in 2005, with 10 
institutions in 5 different countries (4 African + Sweden) collaborating in the research. Moi 
University in Kenya is the lead institution.  Multiplication of material is conducted both at Moi 
University and at KARI centres at Kibos and Kiboko, as well as in farmers’ fields, managed 
under a Memorandum of Understanding (MoU) between Moi University and KARI. 
 
Despite interest expressed by the agrochemical industry for the extraction of juice from sweet 
sorghum varieties for brewing, this innovation has yet not moved beyond the research and 
product development phase. The project has been running for three years and therefore needs 
more time to complete the cycle from the laboratory to performance trials and 
commercialisation. Delays in project execution were, among other things, caused by 
procurement issues.  
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Case 2:  Cassava genetic improvement and clean seed production 
 
It is stated that “a model for production and delivery of virus free planting materials has been 
proposed but is yet to be piloted on station”.  A quality management protocol (QMP) has also 
been developed for use by the multipliers and plant health inspectors.  In all four countries 
involved in this project, a clean seed delivery system has also been developed in collaboration 
with national agriculture research systems, farmers and private sector.  
 
Case 3:  Epuripur:  sweet sorghum for breweries 
 
The case of Epuripur was not in any way supported by the BIO-EARN programme.  Originally, 
the initiative came from a private company, Nile Breweries Uganda Limited (NBL), which 
sought to replace imported barley with local material in brewing its lager beer.  This led to a 
relationship between NBL and a public research institution, the National Semi Arid Resources 
Research Institute (NaSARRI), whereby NaSARRI supplied NBL with six sorghum lines it had 
developed, one of which was Epuripur, found to be eminently suitable for NBL’s purposes, with 
acceptable limits of fat, protein and starch, less tannins, and no fungal contamination.   
 
The relationship between NBL and NSARRI did not endure, however, which was regrettable 
given that NSARRI, apart from distributing seed (free to farmers at the time), ensured good 
agronomic practices, pest control and clean seed.  NBL subsequently engaged a seed company, 
AFRO-KAI Uganda Limited, as its agent to distribute seed to farmers, buy Epuripur from 
farmers and supply NBL.  AFRO-KAI’s role, unlike that of NaSARRI, was a purely commercial 
one. 
 
Case 4:  Virus-free sweet potato vines 
 
In this instance, the role of an individual scientist has been the essential driving force in efforts to 
develop and disseminate the innovation.  The objective was to establish a propagation and 
distribution system for the clean sweet potato materials to farmers.  This was in any event a 
complicated undertaking.  First, the virus was to be eliminated through various in vitro 
techniques.  Second, virus-free materials were to be micropropagated using tissue culture 
techniques.  Third, nucleus seed was to be produced on farm.  Fourth, and finally, clean seed was 
to be distributed to farmers.   
 
An informal partnership was established between the Makerere University Agricultural Research 
Institute at Kabanyolo (MUARIK), a field station of the Department of Crop Science, and a 
private company, AgroGenetics Technologies Limited (AGT) as it was envisaged that AGT 
would multiply and distribute the clean sweetpotato materials to farmers. However, as the 
research progressed, it was realised that sweet potato is a bulky crop and that large areas of land 
would be required to grow and propagate the planting materials.  Moreover, sweetpotato is a low 
value commodity and so cost recovery was not assured. As a consequence, AGT became 
reluctant to participate actively in the project and an effective distribution system has therefore 
not yet been set up. 
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Case 5:  Bioenergy from sisal waste  
 
The case study of bioenergy from sisal waste is also a case where the initiative stems from a 
local private company, Katani Limited, which owns 10 sisal decorticating factories in five sisal 
estates acquired in 1998 following the privatisation of the former parastatal, the Tanzania Sisal 
Authority.   
 
In 2001 Katani Ltd initiated a project known as “Cleaner integral utilization of sisal waste for 
biogas production and bio-fertilizer” after examining results from research on anerobic digestion 
undertaken from 1992 by the Department of Molecular Biotechnology and Biotechnology 
(DMBB) atthe University of Dar es Salaam (UDSM), the Centre for Agricultural Mechnization 
and Rural Technology (CAMARTEC) in Arusha and the Danish Technological Institute in 
Denmark.  This project was implemented following visits to China which provided opportunities 
to become familiar with large-scale biogas plants, gasification and mini-hydro power plants. 
Officials from the Tanzania Sisal Board and employees of Katani Ltd underwent biogas training 
at the Biogas Research Training Centre in China. Chinese and German engineers were contracted 
to construct, in cooperation with local company engineers, the biogas plant at Hale – Tanga, 
which was launched by the President of Tanzania in August 2008.  The Katani bio-energy plant 
produces electricity which is sold to the Tanzania Electricity Supply Company to be fed into the 
national grid. 
 
If Katani is to increase sisal fiber production and bio-energy production it is estimated that some 
24 million sisal plantlets will be required, compared to the current capacity of 600,000 plantlets. 
The Agricultural Research Institute (ARI) at Mlingano, Tanga, currently produces clean and 
improved plantlets for sisal growers using tissue culture for meristemic propagation. However, 
the figure of 24 million plantlets totally outweighs the overall capacity of ARI Mlingano.  
Without substantial increases in its capacity, an appreciable increase in bio-energy production 
from sisal waste is therefore not assured. 
 
In the meantime, DMBB continues its research on the enhancement of anaerobic digestion, but 
its research results have not yet been carried further in the innovation process. 
 
Case 6:  Constructed wetlands for wastewater treatment 
 
The constructed wetlands technological innovation has been developed by the Department of 
Chemical and Process Engineering (DCPE) at the College of Engineering and Technology, 
University of Dar es Salaam, in its research efforts to solve problems of urban domestic and 
industrial waste water disposal in a more affordable and environmentally friendly way. 
 
The Department was able to finance product development in the form of a pilot plant through a 
grant from the BIO-EARN Innovation Fund.  Subsequently, the innovation has been successfully 
diffused for waste water treatment in one school, one college, four municipalities and four 
prisons in Tanzania. 
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UDSM is currently implementing a project aimed at imparting the skills of construction of the 
CWs for waste water treatment in other parts of Tanzania and beyond the borders into Uganda, 
Kenya and Madagascar.    
 
In this case, much of the successful dissemination of the innovation has been due to the efforts of 
a product “champion”, the principal researcher. No IPRs have been taken out on the technology, 
however, and neither the university nor the champion have benefited financially from its success.     
 
III.b Case-study analysis 
 
Of the 6 cases analysed, three have successfully completed the innovation cycle in the sense that 
successful research results have led to the development and diffusion of a specific innovation.   
The other three have not yet completed the innovation cycle but have, as a result of successful 
collaborative research effort, reached the product development stage.     
 
Of the three success stories, one, Epuripur, was developed in response to clear demand on the 
part of a private brewing company.  In the case of bioenergy from sisal waste, Katani was 
stimulated to pursue development of the utilization of sisal waste for biogas production by 
encouraging research results (produced, inter alia, by UDSM) and by the support of the Tanzania 
Sisal Board.  The other environmental innovation, constructed wetlands, has been developed and 
successfully transferred to final users not as the result of perceived economic demand, but as the 
result of the perceived need to alleviate environmental pollution.  It can therefore be termed a 
“public good” technology and, as such, has not been transferred through market mechanisms.  
 
It is striking to note that, except in the case of Epuripur, no mention is made and, apparently, no 
effort has so been made to assess development and/or dissemination costs of the proposed 
innovations.  It would seem important, particularly in circumstances where farmers are not in the 
habit of purchasing seed or planting material, at least to have an estimation of what these costs 
might be.  Similarly, it would seem important to be able to provide reasonably accurate figures 
regarding the costs of constructing wetlands.   
 
The question of demand is crucial in making an assessment as to whether a particular innovation 
may have commercial prospects and can therefore be distributed in a market context, through 
commercial channels, or whether it has no immediate market prospects but, because it is 
considered important for environmental or social reasons (and therefore a “public good” 
technology) needs to be developed and disseminated in a non-market context, through public 
authorities, community groups, farmers’ groups, or NGOs.   Whether an innovation is distributed 
in a market or non-market context, costs are in any event involved and the costs will need to be 
met one way or another. Without an early assessment of market prospects, which would include 
an effort to estimate such costs, obstacles are likely to occur in moving beyond research. 
 
One apparent shortcoming in the cases of the innovations which are still at the product 
development phase is that insufficient effort was made in the original design of the project to 
identify and plot the links in the innovation chain which would need to be connected to complete 
the process.  Clearly, these links will differ according to the nature of the innovation, for 
example, whether an agricultural technology or an environmental technology. They will also 
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differ according to whether or not it is anticipated the innovation will be developed and diffused 
within a market or a non-market context.     
 
Not only is it important to identify potential and necessary partners, it is also important that the 
roles of the different partners involved in the innovation process be clearly defined and their 
roles and responsibilities clearly understood and agreed.  This will avoid misunderstanding or 
disappointment. 
 
Public research institutions are often ill-equipped to move an innovation beyond research.   This 
applies in particular to the universities whose original vocation was confined exclusively to 
research and training.  That vocation remains, but universities are now under growing pressure to 
deliver tangible products from research results. In contrast, the vocation of the public agricultural 
research organisations was, from their establishment, applied research with emphasis on 
agricultural innovation. For that reason, there is an established tradition of links with other public 
institutions such as experimental stations, phytosanitary authorities, seeds certification agencies, 
extension services.   When it comes to environmental/ industrial innovations, where there is no 
such tradition, the links may be less obvious.  
 
Certainly in the past, when budgets have been fixed and allocated they have focussed essentially 
on research and allocations for product development have been neglected.   Particularly if it is 
envisaged that an innovation will be developed and disseminated in a market context and 
therefore by a private company, it is important to be able to demonstrate the relevance and 
economic viability of a given technology.  This implies, in addition to scientific evidence, a 
minimum of economic and/or marketing analysis. 
 
In the case studies analysed, both the research institutions themselves and the scientists who have 
been instrumental not only in generating successful research outcomes but have also played an 
active role in promoting the development of innovations stemming from their research, have not 
been financially rewarded in the course of the dissemination of their innovations.   In the case of 
the constructed wetlands innovation, the innovation “champion” presumably has the moral 
satisfaction of seeing the innovation installed in a number of sites.   
 
It is not obvious whether the public research institutions reap rewards from their successful 
research outcomes, particularly with respect to “public good” technologies.  For example, in the 
case of the constructed wetlands technology, the participating universities have no framework to 
license technologies. In any event, the public research institutions are confronted with the need to 
decide to what extent it is appropriate to become involved in product development and diffusion, 
and what, if any, institutional mechanism would be appropriate for that purpose.  Some public 
research institutions have established technology transfer offices or created commercial units for 
the purpose of seeking appropriate partners and fostering product development and diffusion. 
This is the case with Moi University and the University of Nairobi in Kenya, and the University 
of Dar es Salaam in Tanzania. What is important is that the research institutions devise 
institutional strategies to ensure that successful research outcomes can be further developed. An 
institutional IPR policy would be an important aspect of any such strategy. 
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The case studies suggest that perceptions of the time-frames required to translate successful 
research results into an innovation have been over-optimistic.  And in some instances, it is not 
possible to accelerate the time required.  For instance, while plant-breeding can be accelerated by 
marker-assisted selection, the time taken for small- and large-scale field-testing, to produce and 
multiply seed and for the seed certification process, usually carried out by public bodies, cannot 
be shortened.     
 
In the case of environmental/industrial technology, the setting up of a pilot plant can be a lengthy 
operation as can the period required to demonstrate its effectiveness to potential customers. 
 
While innovation may be a long-term process, public funding is generally short-term. This is 
certainly the case with respect to the bilateral aid agencies.  It is unrealistic to expect that much 
of what can be a lengthy and tortuous innovation process is likely to be achieved within a three-
year period, which is often the period for which funds are allocated, unless plans have been 
carefully laid, with all the necessary links in place and connected. 
 
One of the problems posed by the relative importance of short-term, external funding is that it 
obviates the need for the public research institutions and their scientists to elaborate a longer-
term, more strategic research strategy and agenda, clearly linked to sectoral or national priorities.  
 
In the case studies analysed, the relationship between the national innovation environment (in 
terms of policies, institutions and resources) and innovation outcomes is not obvious.  In the case 
of bioenergy from sisal waste, Katani has benefited – and indeed continues to benefit – from the 
support of the Tanzania Sisal Board which fulfils a promotion role at trade fairs, etc. The 
country’s electricity Act of 2008 allows private generation of electricity and sell to the national 
grid. Prices of such sales are determined by the Tanzania Energy and Water Utility Regulatory 
Authority for small energy providers. However, the extent to which it has benefited from specific 
innovation policy initiatives is not clear. Similarly, in the case of constructed wetlands, personal 
initiatives from researchers have encouraged clients to install the innovation, rather than specific 
policy initiatives. 
 
Whether or not the public research institutions profit financially from successful research effort, 
and whether or not the scientists within those institutions are rewarded, it is important that the 
achievements of the scientific community and the scientific capabilities embedded within the 
public research system be made known to policy-makers, as well as to local entrepreneurs.     
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IV. CONCLUSIONS, POLICY RECOMMENDATIONS AND IMPLICATIONS FOR 
FUTURE BIOSCIENCE INITIATIVES 
 
IV.a Conclusions 
 
This study has been conducted at a time of transition, when innovation is at the centre of policy 
preoccupations in an increasing number of African countries and, more specifically, in the three 
countries which have contributed.  At the same time, it has to be acknowledged that it has been 
conducted at a time when African markets for technological innovation, with the exception of 
South Africa, are still relatively undeveloped. The challenge is then, in the light of the BIO-
EARN and other experiences, to reflect on ways in which innovation can best be fostered.  
 
Innovation is a complex process and the path to success is a function of policies institutions, 
financial and human resources. The key to success lies in forging the links among key actors at 
the appropriate time in the innovation cycle and, more particularly, in the life of the innovation in 
question. And these links will differ according to the type of technological innovation 
(agricultural, environmental, and industrial) and according to whether the innovation will be 
disseminated through commercial (market) or, as in the case of “public good” technologies, non-
market channels. 
 
Whatever the channels, and whether disseminated through commercial channels or as a “public 
good” innovation , there are indispensable phases in the innovation process if it originates with 
research, that is, research, development and diffusion (or final transfer).  Ideally, the final 
consumers of an innovation be they farmers, individual consumers, public or private 
organisations, will become an integral part of the innovation cycle, providing feedback into 
research so that the innovation process becomes a virtuous circle.  
 
If the innovation process is complex, it is also time-consuming. Research can be a lengthy 
process, spanning several years, but research is often the shortest part of the research, product 
development and diffusion cycle. This time frame, particularly the research and product 
development components, is often under-estimated, creating unrealistic expectations and giving 
rise to unsubstantiated claims. 
 
The question of demand for a given innovation is often either ignored or neglected in the design 
of research project proposals, as is the consequent need to decide whether market or non-market 
avenues will be appropriate for technology development and diffusion.   
 
There is no single, one-fits-all solution to successful technological innovation.  Indeed, there may 
be a number of possible pathways to success.  What is important is to identify and to plot the 
essential links as early as possible in the research, development, dissemination process. 
 
The current heavy reliance on external funding has both positive and negative implications.  
Even though the funding is inevitably short-term, it enables scientists to continue to work on 
research which would otherwise not be funded through national sources, exposes them to 
international collaboration and enables them to keep in touch with the state-of-the art in their 
particular fields.  At the same time, it creates a situation where scientists may be competing 
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rather than collaborating within a given institution, and where the external funding may insulate 
the institution from facing the realities of a changing national environment where, increasingly, 
public research institutions are expected, if not to be self-sufficient, at least to generate some 
income. 
 
The new emphasis on the importance of STI and government initiatives taken in that direction 
point to an evolving, more prominent role for public research institutions, where they would need 
to be more outward-looking, more competitive, and engage more with policy-makers. This 
enhanced role would also imply innovative partnering (with the private sector, farmers’ 
organisations, CBOs, as relevant) and a more strategic, longer-term research agenda. 
 
IV.b Policy recommendations   
 
It is unlikely that, in the short term, major changes can be anticipated in the current pattern of 
investment in research.  While governments may have announced plans to increase research 
expenditures, these intentions have not been paralleled by major new incentives to stimulate 
private sector investment in research. While the preponderance of public and donor funding 
continues, more innovative approaches are required for “public good” innovations.  This would 
imply, first and foremost, a greater concentration of effort on forging links between the public 
research institutions and other public and private actors who might play the role of “technology 
brokers” or “intermediaries”. It would also imply greater efforts to exploit opportunities for 
complementarities among a growing number of private non-profit or philanthropic actors. 
 
At present, funding remains concentrated in the research phase of the innovation cycle, with 
inadequate provision made for product development.  Particularly in the case of “public good” 
technologies, funding may be required not only for product development, but also for initial 
dissemination through non-market channels and should therefore be more evenly distributed 
throughout the innovation cycle. Dissemination through non-market channels also provides 
opportunities for a “demonstration effect” which in turn stimulates demand and enhances 
opportunities for the creation of local enterprises. 
 
Research funding depends heavily at present on external funding, by bilateral and multilateral 
donors and philanthropic foundations. To correct this bias, it would be necessary for 
governments either to increase their own funding or, alternatively or in parallel, to provide 
incentives for private investment in research.  At the same time, it would be necessary to provide 
incentives to stimulate the development of technology markets and, in particular, the creation of 
local enterprises.  These might include: the provision of matching funds for product 
development, innovation funds, “bridging finance” mechanisms, and the provision of micro-
credit in support of local entrepreneurs and local farmers, particularly when they may be 
purchasing improved seed or planting material for the first time. 
 
Dependence on external funding, as suggested earlier, can be a double-edged sword in the sense 
of enabling researchers to pursue personal interests which may be at variance with national 
research priorities.  Similarly, donor priorities may differ from national priorities.  One way of 
minimising inherent conflict would be for governments to provide clear policies and guidance 
with respect to national R&D priorities and strategies. 
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In this transitional period, when governments are designing policies in support of STI but when 
public funding for research is only one of many urgent priorities and when there is as yet little 
private funding, the public research institutions have a crucial role to play.  That role would 
imply a change of mind-set, a need to be more outward-looking, to form innovative partnerships 
and to seek opportunities to generate income and enhance their independence.  It would imply 
more open research and innovation teams in the sense of promoting interdisciplinarity, 
encompassing not only science, but also economics, marketing and policy. 
 
Finally, it would also imply the need to play an active role in communicating with decision-
makers to enhance awareness of the capacities of the local scientific community and, at the same 
time, to elicit support for that community. 
 
During its lifetime, the BIO-EARN programme has played a significant role in this regard.   It 
has also been instrumental in facilitating policy developments relating to biotechnology and 
biosafety. 
 
The regional dimension of research and innovation programmes such as BIO-EARN adds 
complexity to the innovation process and its policy environment.  It raises the question of the 
prospects for regional policies, regional harmonization of regulations, regional procurement, 
and regional markets. 
 
IV.c Implications for future bioscience initiatives 
 
The foregoing suggests some important implications for the design and implementation of the 
future bioscience initiatives, including the newly established Bio-Innovate programme that will 
partially succeed the BIO-EARN programme.  These include: 
 
 The need to think beyond science and scientific enquiry in project design and to take into 
account the question of demand in both an economic and social sense. This is essential to 
be able to make realistic assumptions regarding the prospects of  translating research into 
an innovation  in the farmer’s field or in the hands of end-users and to plot realistic 
innovation pathways. 
 
 The need for disciplines other than science in project teams. African scientists and public 
research institutions in African countries do not in general benefit from the well-
established infrastructure and innovation environment which characterises similar 
institutions in industrialised countries.  As emphasized earlier, technology markets in 
most African countries are still relatively undeveloped.  It is all the more important, 
therefore, that they are able to add economic, market and/or social perspectives to their 
research efforts if they are intended to result in a technological innovation 
 
 Whether or not it is envisaged that research will lead to an innovation to be developed 
and disseminated in a market or non-market context, funds will be required for product 
development.  Provision should therefore be made to allocate adequate funds to product 
development and/or to facilitate the innovation process. 
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 The BIO-EARN programme was unique in that it had a policy component. Lessons from 
the BIO-EARN experience strongly suggest that, rather than be designed as a separate 
component within a scientific programme, it would be more effective for policy issues to 
be included as an integral part of individual projects. 
 
 
  
 
